Delivery Order SPE2DB20D1100-SPE2DB24FA5D3

Award Date 3/1/24
Potential Completion Date 3/22/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORSERDU 345 MG TABLET 30S. The contract has a firm fixed price of $13,463.77 and a completion date of September 20, 2024. This award is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,927.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,920.91, is a delivery order for the pharmaceutical product ORSERDU 345 MG TABLET 30S. The contract has an ultimate completion date of April 25, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $13,929.10 for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $13,920.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of ORSERDU 345 MG TABLET 30S, a medical product, with a period of performance through February 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,841.82 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 20, 2025. The award is not associated with a set-aside designation. The contract covers the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a...
This federal contract award, with the ID SPE2DX15D3012|SPE2DX25F8LU9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $13,920.91 firm fixed-price delivery order is for the medical commodity "ORSERDU 345 MG TABLET 30S" and has an ultimate completion date of February 4, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a delivery order under contract SPE2DB24FE0U0 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4565965150 - ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The award has a ceiling value of $13,463.77 and a completion date of October 21, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,041.75 award is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
This is a $17,716.05 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as the prime contractor, is providing a range of specialty, brand name, generic, and over-the-counter medications, as well as...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA5D3
    Delivery Order

This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,463.77 contract is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a completion date of March 22, 2024.

The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is issued under a larger, single-award indefinite delivery contract held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/31/24, 10:44 AM